High Body Mass Index and Response to Anti-Tumor Necrosis Factor Therapy in Pediatric Crohn's Disease

Dawn R. Ebach, Traci W. Jester, Joseph A. Galanko, Ann M. Firestine, Rana Ammoury, Jose Cabrera, Julie Bass, Phillip Minar, Kelly Olano, Peter Margolis, Kelly Sandberg, Tiffany M. Linnville, Jess Kaplan, Lisa Pitch, Steven J. Steiner, Dorsey Bass, Jonathan Moses, Jeremy Adler, Ajay S. Gulati, Prateek WaliDinesh Pashankar, Anastasia Ivanova, Hans Herfarth, David A. Wohl, Keith J. Benkov, Jennifer Strople, Jillian Sullivan, Jeanne Tung, Zorela Molle-Rios, Shehzad A. Saeed, Athos Bousvaros, Michael D. Kappelman

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1110-1116
Number of pages7
JournalAmerican Journal of Gastroenterology
Volume119
Issue number6
DOIs
StatePublished - Jun 1 2024
Externally publishedYes

ASJC Scopus Subject Areas

  • Hepatology
  • Gastroenterology

Keywords

  • Crohn disease
  • adalimumab
  • body mass index
  • infliximab
  • therapeutic drug monitoring

Cite this